The ink was barely dry on…
The ink was barely dry on AstraZeneca’s announcement of a [...]
Moderna has out-licensed a rare…
Moderna has out-licensed a rare disease drug candidate to Recordati, [...]
Cardiff is churning its leadership…
Cardiff is churning its leadership team as the biotech advances [...]
AI-fueled Formation Bio has inked…
AI-fueled Formation Bio has inked another licensing deal for a [...]
Two and a half years after Sanofi…
Two and a half years after Sanofi unveiled to investors [...]
Roche has waved goodbye to an…
Roche has waved goodbye to an inflammation drug from Kiniksa—as [...]
AstraZeneca has outlined plans to…
AstraZeneca has outlined plans to invest $15 billion in China [...]
A brain tumor has prompted the FDA…
A brain tumor has prompted the FDA to put clinical [...]
CalciMedica’s stock nosedived…
CalciMedica’s stock nosedived after the biotech abandoned a phase 2 [...]
Boehringer Ingelheim has shared…
Boehringer Ingelheim has shared more phase 2 data on its [...]